Cited by — The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis.
No admitted local citation edges point to this work yet.
